全文获取类型
收费全文 | 127篇 |
免费 | 9篇 |
专业分类
儿科学 | 18篇 |
基础医学 | 16篇 |
口腔科学 | 18篇 |
临床医学 | 22篇 |
内科学 | 12篇 |
皮肤病学 | 1篇 |
神经病学 | 17篇 |
特种医学 | 10篇 |
外科学 | 3篇 |
综合类 | 4篇 |
眼科学 | 1篇 |
药学 | 10篇 |
肿瘤学 | 4篇 |
出版年
2022年 | 1篇 |
2021年 | 1篇 |
2020年 | 4篇 |
2019年 | 1篇 |
2016年 | 3篇 |
2015年 | 3篇 |
2014年 | 1篇 |
2013年 | 2篇 |
2012年 | 2篇 |
2011年 | 5篇 |
2010年 | 4篇 |
2009年 | 2篇 |
2008年 | 4篇 |
2007年 | 6篇 |
2006年 | 4篇 |
2005年 | 3篇 |
2004年 | 2篇 |
2003年 | 4篇 |
2001年 | 4篇 |
1999年 | 3篇 |
1998年 | 4篇 |
1997年 | 9篇 |
1996年 | 8篇 |
1995年 | 3篇 |
1994年 | 3篇 |
1993年 | 2篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1990年 | 2篇 |
1989年 | 4篇 |
1988年 | 5篇 |
1987年 | 2篇 |
1986年 | 2篇 |
1985年 | 4篇 |
1984年 | 2篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1980年 | 7篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1973年 | 2篇 |
1972年 | 1篇 |
1971年 | 2篇 |
1967年 | 1篇 |
1966年 | 2篇 |
1963年 | 1篇 |
1953年 | 1篇 |
排序方式: 共有136条查询结果,搜索用时 15 毫秒
61.
IB PAUL SEWERIN 《European journal of oral sciences》1989,97(6):559-564
Abstract— In the treatment with osseointegrated implants ad modum Brånemark a radiographic control of the fixture-abutment connection is recommended. The purpose of the present study was to analyze the possibilities of detecting incomplete connection by radiography using the recommended technique. In an experimental model the influence of film density, orientation of the fixture hexagon, angulation between film plane and fixture axis, leakage width, and partial connection were analyzed. Slits of 0.05 mm were detectable under optimum projection conditions. On the other hand, slits of 0.1 mm were obscured even at deviations of 5°. A number of factors, e.g. low density level and "unfavorable" orientation of the hexagon in relation to the X-ray beam, reduce the possibilities of detecting slits. It is concluded that in clinical cases a demonstration of incomplete fixture-abutment connection by the use of the recommended radiographic technique radiography to some extent is fortuitous, and that radiographic control has certain limitations. 相似文献
62.
63.
Yoshitaka Kumakura Erik H. Danielsen Albert Gjedde Ingo Vernaleken Hans-Georg Buchholz Andreas Heinz Gerhard Gründer Peter Bartenstein Paul Cumming 《NeuroImage》2010,49(4):2933-2939
PET studies with the DOPA decarboxylase substrate 6-[18F]fluoro-l-DOPA (FDOPA) reveal the storage of [18F]-fluorodopamine within synaptic vesicles, mainly of dopamine fibres. As such, FDOPA PET is a sensitive indicator of the integrity of the nigrostriatal dopamine innervation. Nonetheless, there have been several reports of focal elevations of FDOPA utilization in brain of patients with Parkinson's disease (PD), all based on reference tissue methods. To investigate this phenomenon further, we used voxel-wise steady-state kinetic analysis to search for regions of elevated FDOPA utilization (K; ml g? 1 min? 1) and steady-state trapping (Vd; ml g? 1) in a group of well-characterized patients with early, asymmetric PD, who were contrasted with an age-matched control group. Subtraction of the population mean parametric maps revealed foci of increased FDOPA utilization K (+ 25%) in the bilateral medial nucleus accumbens, whereas the expected declines in the trapping of FDOPA were seen in the caudate and putamen. This observation suggests hyperfunction of catecholamine fibres innervating specifically the limbic striatum, which could guide the design of future prospective FDOPA-PET studies of the impulse control disorders occurring in some PD patients under treatment with dopamine agonists. A focus of increased FDOPA influx and also Vd was detected in the periaqueductal grey, consistent with some earlier reports based on reference tissue analysis. Increased FDOPA trapping in the periaqueductal grey of PD patients seems consistent with recent reports of increased activity of serotonin neurons in a rat model of parkinsonism. 相似文献
64.
Therapeutic Drug Monitoring (TDM) of psychotropic drugs is strongly depending on the validity of recommended therapeutic plasma concentration reference ranges. Rational pharmacotherapy is based on the assumption that plasma concentrations are directly related to target occupancy by the respective drug. Here we show that positron emission tomography (PET) of molecular drug targets in the brain (neuroreceptors and transporters) allows for establishment of these relationships, thereby providing guidance for TDM services. Associations between brain target occupancy, plasma concentrations, and clinical effects and adverse reactions will be discussed for the most commonly used antidepressant and antipsychotic drugs. 相似文献
65.
Zusammenfassung
Die Gruppe der “atypischen” Neuroleptika ist keine einheitliche Substanzklasse, sondern sowohl nach pharmakologischen als
auch nach klinischen Kriterien sehr heterogen. Die überg?nge von dem prototypischen “atypischen” Neuroleptikum Clozapin zu
den “konventionellen” Neuroleptika erscheinen flie?end. Anhand der pr?klinischen Besonderheiten dieser Substanzen und ihrer
Charakteristika in SPECT- und PET-Studien werden die wesentlichen Konzepte diskutiert, die man heute für die “Atypie” eines
Neuroleptikums verantwortlich macht. Dazu z?hlen insbesondere der kombinierte Antagonismus von D2-artigen Dopamin- und 5-HT2-Serotoninrezeptoren und die pr?ferentielle Beeinflussung mesolimbischer dopaminerger Neurone. Daneben sind für einzelne Substanzen
m?glicherweise Affinit?ten für spezifische Neurotransmitterrezeptoren bzw. die Interaktion mit anderen nicht-dopaminergen
Systemen bedeutsam. Auch die Bedeutung einer relativ niedrigen Affinit?t zu D2-artigen Dopaminrezeptoren und die Bindung an Dopamin-Autorezeptoren werden diskutiert. Die Vielfalt der m?glichen Mechanismen
verdeutlicht, dass es wahrscheinlich keine einheitliche, pharmakologisch begründbare Konzeption von “atypischem” Neuroleptikum
gibt. Verschiedene biologische Mechanismen charakterisieren eine heterogene Substanzgruppe, die sich auch in ihren klinischen
Eigenschaften teilweise erheblich unterscheiden.
相似文献
66.
Parametric mapping of binding in human brain of D2 receptor ligands of different affinities. 总被引:8,自引:0,他引:8
Thomas Siessmeier Yun Zhou Hans-Georg Buchholz Christian Landvogt Ingo Vernaleken Markus Piel Ralf Schirrmacher Frank R?sch Mathias Schreckenberger Dean F Wong Paul Cumming Gerhard Gründer Peter Bartenstein 《Journal of nuclear medicine》2005,46(6):964-972
(11)C-Raclopride has been widely used for PET studies of dopamine D(2/3) receptors in human brain. The long half-life of (18)F may impart advantages to the novel moderate-affinity benzamide (18)F-desmethoxyfallypride and its high-affinity congener (18)F-fallypride for competition studies and for detection of extrastriatal binding. However, the in vivo kinetics of these compounds and the quantification approaches for parametric mapping of their specific bindings have not been systematically compared. METHODS: Dynamic emission recordings of the 3 tracers were obtained in groups of healthy subjects. A conventional model, graphical analysis using metabolite-corrected arterial inputs, and models with reference tissue inputs were used to calculate voxelwise parametric maps of the equilibrium distribution volume (V(d)) and the binding potential (BP) of the 3 radioligands in brain. To test for bias, voxelwise kinetic results were compared with those obtained by volume-of-interest (VOI) analysis. RESULTS: The V(d) and BP estimates obtained by VOI analysis did not differ from the mean of voxelwise estimates in the same striatal volumes. In striatum, the mean (18)F-desmethoxyfallypride BP ranged from 1.9 to 2.5, whereas the mean (11)C-raclopride BP ranged from 3 to 4, depending on the method used for calculation. In contrast, the mean BP of (18)F-fallypride ranged from 16 to 27 in striatum and could also be readily quantified in the thalamus. CONCLUSION: Reference tissue methods for the voxelwise calculation of binding parameters are suitable for parametric mapping of the 3 dopamine D(2/3) receptor ligands. 相似文献
67.
Spitzer RL Kroenke K Williams IB JB 《英国医学杂志》2007,10(2):101-102
问题:广泛性焦虑障碍(GAD)-7量表的诊断精确性如何?
方法
设计:采用盲法比较GAD-7量表与DSM—Ⅳ中的GAD标准。[第一段] 相似文献
68.
Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo. 总被引:2,自引:0,他引:2
Gerhard Gründer Ingo Vernaleken Matthias J Müller Eugen Davids Nilufar Heydari Hans-Georg Buchholz Peter Bartenstein Ole L Munk Peter Stoeter Dean F Wong Albert Gjedde Paul Cumming 《Neuropsychopharmacology》2003,28(4):787-794
The antipsychotic effect of neuroleptics cannot be attributed entirely to acute blockade of postsynaptic D(2)-like dopamine (DA) receptors, but may arise in conjunction with the delayed depolarization block of the presynaptic neurons and reduced DA synthesis capacity. Whereas the phenomenon of depolarization block is well established in animals, it is unknown if a similar phenomenon occurs in humans treated with neuroleptics. We hypothesized that haloperidol treatment should result in decreased DA synthesis capacity. We used 6-[(18)F]fluoro-L-dopa (FDOPA) and positron emission tomography (PET) in conjunction with compartmental modeling to measure the relative activity of DOPA decarboxylase (DDC) (k(D)(3), min(-1)) in the brain of nine unmedicated patients with schizophrenia, first in the untreated condition and again after treatment with haloperidol. Patients were administered psychometric rating scales at baseline and after treatment. Consistent with our hypothesis, there was a 25% decrease in the magnitude of k(D)(3) in both caudate and putamen following 5 weeks of haloperidol therapy. In addition, the magnitudes of k(D)(3) in cerebral cortex and thalamus were also decreased. Psychopathology as measured with standard rating scales improved significantly in all patients. The decrease of k(D)(3) in the thalamus was highly significantly correlated with the improvement of negative symptoms. Subchronic treatment with haloperidol decreased the activity of DDC in the brain of patients with schizophrenia. This observation is consistent with the hypothesis that the antipsychotic effect of chronic neuroleptic treatment is associated with a decrease in DA synthesis, reflecting a depolarization block of presynaptic DA neurons. We link an alteration in cerebral catecholamine metabolism in human brain with the therapeutic action of neuroleptic medication. 相似文献
69.
ESBEN AAGAARD CLAUS DONSLUND ANN WENZEL IB SEWERIN 《European journal of oral sciences》1991,99(2):166-172
Abstract – The aim of this study was to evaluate the effect on subtraction image quality of number of a) gray shades sampled during camera recording, and b) reference points positioned in the two images to be subtracted. Intraoral radiographs were obtained in each of 12 patients, one at 0° and one at 15° horizontal angulation in a standardized recording procedure. The radiographs were videorecorded twice sampling 1) 160–180 and 2) 200–220 shades of gray. The 0° radiographic image was digitally copied. Subtractions were performed between the identical (0°/0°) and the non-identical (0°/15°) radiographs from both gray shade samples after positioning 5, 10, 15, and 20 reference points, respectively, in each of the images to be subtracted. The standard deviation in the subtraction image histogram was used as the test parameter for image quality. No differences existed between image quality obtained from the radiographs sampled using 160–180 and 200–220 shades of gray (P>0.05). The standard deviation fell continuously, the more reference points were positioned in the images. For the 0°/0° images the difference was statistically significant between the 5 and 10 point images ( F= 0.045) while for the 0°/15° images differences existed between 5 and 10 point images (P = 0.077) and the 10 and 15 point images ( P= 0.048). The precision of reference point positioning as evaluated in the two identical images was satisfactory, the divergence being on average 1.4 pixels. The conclusion from cost/benefit analysis was that, when working with subtraction radiography, time should not be spent adjusting camera diaphragm to utilize the full range of gray shades but rather on a precise positioning of 10–15 reference points in the images to be subtracted. 相似文献
70.
JE Pirkis GA Blashki AW Murphy IB Hickie L Ciechomski 《Australia and New Zealand Health Policy》2006,3(1):4